Skip to main content

Concord Medical Services Holdings Ltd

corporate_fare Company Profile

Concord Medical Services Holdings Ltd

CCM·NYSE·Healthcare·CIK 0001472072

Concord Medical Services Holdings Ltd operates a network of cancer hospitals and cooperative centers in China. As of December 31, 2025, the company had eight cooperative centers located within six hospitals, spread across six cities in five provinces and administrative regions in China. These cooperative centers are a key part of the company's business model, with growth historically driven by new arrangements with hospital partners or acquisitions. In addition to its cooperative centers, Concord Medical Services Holdings Ltd is establishing its own cancer hospitals and clinics. As of December 31, 2025, the company had four self-owned cancer hospitals and clinics in operation in China. These include one comprehensive cancer hospital, two cancer diagnosis and treatment clinics, and one imaging diagnosis center. The company was also constructing Shanghai Hospital as of December 31, 2025. The expansion of both cooperative centers and self-owned facilities directly impacts patient visits and revenue growth. The range and mix of services provided, along with the cost of medical equipment, also affect the company's financial performance. New facilities typically experience a ramp-up period where operating efficiency may be lower than established ones.

Concord Medical Services Holdings Ltd (NYSE:CCM) is a publicly traded company in the Healthcare sector. Wiseek monitors CCM SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Concord Medical Faces Potential Deconsolidation of Key Subsidiary, Raising Financial Uncertainty
  • Subsidiary Concord Healthcare Completes HK$68M Convertible Bond Issue
  • Concord Healthcare Subsidiary Reports Executive Director Resignation Amidst Parent's Going Concern Warning
  • Concord Medical Discloses Going Concern Doubt, Reports Significant Losses and Material Weakness in Internal Controls

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
¥460.51M CNY
Net Income
-¥92.81M CNY
Diluted EPS
-¥0.71 CNY
Op. Cash Flow
-¥201.82M CNY
Free Cash Flow
-¥258.15M CNY
Gross Profit
¥25.82M CNY
Operating Income
-¥261.49M CNY
Cash & Equivalents
¥297.79M CNY
Total Debt
¥3.02B CNY
Debt / Equity
-1.43×
Net Margin
-20.2%
Shares Outstanding
130.25M sh
Source: 20-F · filed 2026-04-29 · accession 0001104659-26-050692

Insider Transactions

CCM files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with C →
$4.54
52-week range · as of 2026-05-18 $3.18 – $10.77
Market cap
$19.14M
Volume
5.6K (0.1× avg)
3-mo avg 56.1K
Live data · 2026-06-14 06:07 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CCM - Latest Insights

CCM
May 18, 2026, 6:59 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $5.14
Real-time Price: $4.54 info
Change: -$0.600 (-12%) info
Market Cap: $19.136M info
CCM
May 13, 2026, 4:15 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $5.35
Real-time Price: $4.54 info
Change: -$0.810 (-15%) info
Market Cap: $19.136M info
CCM
May 13, 2026, 6:01 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $5.30
Real-time Price: $4.54 info
Change: -$0.760 (-14%) info
Market Cap: $19.136M info
CCM
Apr 29, 2026, 6:08 AM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $3.81
Real-time Price: $4.54 info
Change: +$0.730 (+19%) info
Market Cap: $19.136M info